Inflamax
Latest round
- Angel
Last raised
- Oct 2023
Total raised
- Undisclosed
Investors
- 1
About Inflamax
Based in Guangzhou, China, and founded in 2022, Inflamax operates as a biopharmaceutical company that focuses on innovative drug for immune and inflammatory diseases. The founder, Micky D. Tortorella was a chief technology officer of the Guangzhou Biomedicine and Health Research Drug R&D Center of the Chinese Academy of Sciences. Inflamax focuses on developing innovative drugs targeting the field of immune inflammation. The company has also launched four major FIC/BIC R&D pipelines in the field of immune inflammation. The products can be used to treat a variety of conditions including cancer, pain, neurological disorders, and osteoarthritis. The company generates revenue by developing innovative drug for immune and inflammatory diseases. The company will use the funds to support the first human clinical trial of MAX-001 in the treatment of advanced refractory solid tumors.
Who invested in Inflamax
1 investor across 1 round
See all investors in Inflamax
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Oct 20, 2023
Amount
Undisclosed
Investors
Questions about Inflamax
Who invested in Inflamax?
Inflamax has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inflamax raised?
Inflamax has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Inflamax last raise money?
Inflamax's most recent round on record is a Angel, in Oct 2023.
What does Inflamax do?
Based in Guangzhou, China, and founded in 2022, Inflamax operates as a biopharmaceutical company that focuses on innovative drug for immune and inflammatory diseases.
Where is Inflamax headquartered?
Inflamax is headquartered in Guangzhou, China.
Which VCs invest in companies like Inflamax?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Inflamax's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Inflamax? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.